Patients with MCC often exhibit oligoclonal lymphocyte-mediated and antibody-mediated immunity against MCC tumor antigens [2–4], with complex arrangements of immune cells, including B cells, CD4+ and CD8+ T cells, macrophages and regulatory T cells [5]. This evidence concerns the gene CD8A and Merkel cell skin cancer.